News
COR
317.58
-0.73%
-2.32
Wells Fargo Issues a Buy Rating on Cencora (COR)
TipRanks · 2d ago
Weekly Report: what happened at COR last week (0406-0410)?
Weekly Report · 2d ago
All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside
Seeking Alpha · 3d ago
Weekly Report: what happened at COR last week (0330-0403)?
Weekly Report · 04/06 09:06
2 S&P 500 Stocks with Exciting Potential and 1 We Ignore
Barchart · 04/02 03:26
Cencora Announces Date and Time for Second Quarter Fiscal 2026 Earnings Release
Barchart · 04/01 15:30
Marvell jumps as Nvidia invests $2B; companies announce strategic partnership
Seeking Alpha · 03/31 12:20
1 Large-Cap Stock for Long-Term Investors and 2 We Avoid
Barchart · 03/31 03:10
Weekly Report: what happened at COR last week (0323-0327)?
Weekly Report · 03/30 09:06
Cencora to buy EyeSouth Partners’ retina business for $1.1B
Seeking Alpha · 03/24 11:04
Cencora to Acquire EyeSouth Retina Business for Expansion
TipRanks · 03/23 12:00
Cencora signs agreement to acquire EyeSouth Partners’ retina business for $1.1B
TipRanks · 03/23 11:05
Weekly Report: what happened at COR last week (0316-0320)?
Weekly Report · 03/23 09:06
Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and Novartis in focus
Seeking Alpha · 03/22 13:05
Analysts Offer Insights on Healthcare Companies: Nuvation Bio (NUVB) and Cencora (COR)
TipRanks · 03/18 12:10
Wells Fargo Keeps Their Buy Rating on Cencora (COR)
TipRanks · 03/18 10:45
Barclays Sticks to Their Buy Rating for Cencora (COR)
TipRanks · 03/18 06:05
1 Healthcare Stock with Exciting Potential and 2 We Ignore
Barchart · 03/18 05:28
Midday Fly By: Nvidia bullish on AI revenue, MasterCard to acquire BVNK
TipRanks · 03/17 15:51
Stock Indexes Advance as Chip Makers and Travel Stocks Rally
Barchart · 03/17 15:36
More
Webull provides a variety of real-time COR stock news. You can receive the latest news about Cencora Inc. through multiple platforms. This information may help you make smarter investment decisions.
About COR
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.